Annual General Meeting of Q-Med AB (publ)

Annual General Meeting of Q-Med AB (publ) 

The Board of Directors of Q-Med AB (publ) has of today published a notice to
attend the Annual General Meeting, which will be held on Tuesday April 29 at 3
p.m. on 
Q-Med's premises. Entrance from Fyrisvallsgatan 5, Uppsala, Sweden. A notice has
been published in Upsala Nya Tidning, Svenska Dagbladet and in Post- och Inrikes
Tidningar (Swedish Official Gazette). The complete notice of the Annual General
Meeting in English can be found on the corporate web site www.q-med.com, and is
also attached.

Q-Med AB (publ)

The Board


Queries should be addressed to:
Madelene Sandgren, Director Investor Relations and Corporate Communications 
Tel: +46 (0) 70 974 9015 
Kristin Ermanbriks, Manager Corporate Administration
Tel: +46 (0) 70 974 9071

Q-Med AB is a rapidly growing and profitable biotechnology/medical device
company. The company develops, manufactures, markets, and sells primarily
medical implants. The majority of the products are based on the company's
patented technology, NASHA™, for the production of stabilized non-animal
hyaluronic acid. The product portfolio today contains: Restylane® for filling
lines and folds, contouring and creating volume in the face, Macrolane™ for body
contouring, Durolane™ for the treatment of osteoarthritis of the hip and knee
joints, Deflux® for the treatment of vesicoureteral reflux, VUR, (a malformation
of the urinary bladder) in children, and Solesta™ for the treatment of fecal
incontinence. Sales are made through the company's own subsidiaries or
distributors in over 70 countries. Q Med today has just over 700 coworkers, with
close to 500 at the company's head office and production facility in Uppsala,
Sweden. Q-Med AB is listed in the Mid Cap segment of the OMX Nordic Exchange in
Stockholm.


Q-Med AB (publ), Seminariegatan 21, SE-752 28 Uppsala, Sweden. Corporate
identity number 556258-6882.
Tel: +46(0)18-474 90 00. Fax: +46(0)18-474 90 01. E-mail: info@q-med.com. Web:
www.q-med.com.

In USA, Q-Med AB's affiliate is the wholly-owned subsidiary Q-Med Scandinavia,
Inc.